ZR-75-1 PDGFRB [ZR-PDGFRB (4147)] cell line
Contributors
| Inventor | Institute |
|---|---|
| Lambert Dorssers | Erasmus University Medical Center (Erasmus MC) |
| SKU: | 154634 |
|---|---|
| Product description: | Breast cancer is widely and effectively treated with endocrine treatment. However, in advanced disease cases the tumours will eventually progress into an estrogen-independent and therapy-resistant phenotype.Seven genes including AKT1, AKT2, BCAR1, BCAR2, BCAR3, EGFR2 and GRB7 have been shown to directly underlie estrogen independence in human breast cancer cells. This cell line is part of a panel of 16 cell lines (Cat No 154621-154635, 154642) which have been transfected with these genes, plus the parental (Cat No 154547). |
| Alternate name: | Platelet Derived Growth Factor Receptor Beta; PDGFR1; CD14B |
| Production details: | Retroviral particles containing PDGFRB cDNA were produced by transient transfection of Phoenix-Ampho packaging cells using FuGENE6. ZR-75-1 cells were incubated with viral particles in the presence of 4ug/ml polybrene and 1nmol/L estradiol. Three days after transfection cells were cultured in medium supplemented with G418 and resistant colonies were expanded. |
| Parental cell line: | ZR-75-1 |
| Disease: | Cancer |
| Cat. #: | 154634 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Breast cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Breast |
| Model: | Cancer Model |
| Cancer Types In Detail: | Mammary ductal carcinoma |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | RPMI 1640 medium supplemented with 10% heat-inactivated bovine serum (RBCS) and 1 nM 17?-estradiol |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
van Agthoven et al. 2010. Endocr Relat Cancer. 17(1):215-30. PMID: 19966015. |
|---|
Images
View Gallery
Product Images
161192.jpg
